Benjamin Derman, MD
American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Hematology, American Board of Internal Medicine
|Director of Multiple Myeloma Clinic and Tumor Board
University of Chicago, Chicago, IL
Hematology/Oncology, University of Chicago, Chicago, IL
His research endeavors are focused on MRD in myeloma: novel ways to assess for residual disease, how to use MRD to guide clinical decision making, and how MRD may be used to identify possible cures. Additionally, he is actively engaged in researching novel CAR T-cell therapies and other immunotherapies for patients with myeloma.